Aperio Group’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $1.23M | Buy |
43,528
+522
| +1% | +$14.8K | ﹤0.01% | 1472 |
|
|
2020
Q3 | $1.08M | Sell |
43,006
-1,679
| -4% | -$42.2K | ﹤0.01% | 1412 |
|
|
2020
Q2 | $1.09M | Sell |
44,685
-4,340
| -9% | -$106K | ﹤0.01% | 1373 |
|
|
2020
Q1 | $725K | Sell |
49,025
-2,952
| -6% | -$43.7K | ﹤0.01% | 1440 |
|
|
2019
Q4 | $844K | Buy |
51,977
+7,694
| +17% | +$125K | ﹤0.01% | 1517 |
|
|
2019
Q3 | $575K | Buy |
44,283
+9,732
| +28% | +$126K | ﹤0.01% | 1681 |
|
|
2019
Q2 | $448K | Buy |
34,551
+21,570
| +166% | +$280K | ﹤0.01% | 1848 |
|
|
2019
Q1 | $205K | Buy |
+12,981
| New | +$205K | ﹤0.01% | 2152 |
|